I now have comprehensive content to write a thorough answer. Let me compile everything.
Organophosphate (OP) Poisoning: Pediatric Management
Why Children Are More Vulnerable
Children carry greater risk than adults for several reasons:
- Smaller body mass means a given dose produces higher mg/kg exposure
- Lower baseline cholinesterase activity - less enzyme reserve means inhibition reaches toxic threshold faster
- Higher surface area-to-body-mass ratio increases transdermal absorption
- Developing nervous systems are more sensitive to neurotoxic effects, including the neurodevelopmental effects of chronic low-level exposure
Organophosphates are absorbed via dermal, GI, inhalation, and conjunctival routes - all relevant in pediatric exposures (flea dips, agricultural spray, contaminated food, household products). - Tintinalli's Emergency Medicine, p. 1342
Pathophysiology (Brief Recap)
OPs irreversibly phosphorylate acetylcholinesterase (AChE), leading to acetylcholine (ACh) accumulation at:
- Muscarinic sites (exocrine glands, smooth muscle, heart)
- Nicotinic sites (skeletal muscle neuromuscular junction, autonomic ganglia)
- CNS sites
"Aging" = permanent irreversible AChE-OP bonding - time to aging varies from minutes to >24 hours depending on agent. Once aged, new enzyme synthesis (weeks) is the only recovery route. - Tintinalli's Emergency Medicine, p. 1343
Clinical Presentation
Muscarinic (SLUDGE / DUMBELS):
| SLUDGE | DUMBELS |
|---|
| Salivation | Defecation, Urination, Miosis |
| Lacrimation | Bradycardia, Bronchospasm, Bronchorrhea |
| Urination | Emesis |
| Defecation | Lacrimation |
| GI cramping | Salivation |
| Emesis | |
Also: miosis, bronchospasm/bronchorrhea (the primary killer), bradycardia, hypotension.
Nicotinic:
- Muscle fasciculations, cramps, weakness
- Progression to paralysis and areflexia (can mask seizure activity)
- Respiratory muscle paralysis - the most common cause of death
CNS:
- Anxiety, restlessness, seizures, coma
Key pediatric note: The majority of severely poisoned patients have altered mental status, pinpoint pupils, diaphoresis, and respiratory distress. - Tintinalli's Emergency Medicine, p. 1343
Four Recognized Clinical Syndromes
- Acute cholinergic crisis - immediate onset, classic SLUDGE/nicotinic/CNS findings
- Intermediate syndrome - 1-5 days post-exposure, seen in up to 40% after ingestion; neck flexor and proximal limb paralysis, cranial nerve involvement, respiratory failure (no cholinergic excess); resolves within ~7 days
- Chronic toxicity - symmetrical sensorimotor axonopathy (mostly agricultural workers)
- OP-induced delayed neuropathy - cognitive dysfunction, peripheral neuropathy, extrapyramidal signs - Tintinalli's Emergency Medicine, p. 1343
Management
Step 1: Decontamination
- Remove clothing (can reduce ongoing absorption by up to 80%)
- Wash skin and hair thoroughly with soap and water
- Eye irrigation for ocular exposure
- Healthcare staff must use PPE (gloves, gown) to avoid secondary contamination
Step 2: Airway & Respiratory Support
- This is the priority - death is from respiratory failure
- Early endotracheal intubation for respiratory muscle weakness, excessive secretions, or declining consciousness
- Succinylcholine should be avoided (or used cautiously) - OP inhibits pseudocholinesterase, prolonging neuromuscular blockade; use rocuronium instead if paralysis needed
- Suction bronchorrhea aggressively
Step 3: Atropine (Anti-muscarinic Antidote)
Atropine is the cornerstone of treatment.
| Parameter | Pediatric Dose |
|---|
| Initial IV/IO bolus | 0.05 mg/kg IV |
| Repeat interval | Every 5-10 minutes, doubling each dose |
| Endpoint | Drying of respiratory secretions + improved respiratory effort + normalization of respiratory rate |
| Maintenance infusion (once stabilized) | 10-20% of total loading dose per hour |
- Tachycardia and mydriasis are not endpoints to stop atropine - only secretion drying is
- Expect very large total doses (200-500 mg in adults; children proportionally large) - do not be alarmed
- Atropine does not reverse nicotinic effects (muscle paralysis, fasciculations)
-
- Rosen's Emergency Medicine, p. 1492
Step 4: Pralidoxime / 2-PAM (Oxime - AChE Reactivator)
Pralidoxime reactivates phosphorylated AChE if given before aging occurs.
Indications: Moderate-severe poisoning - defined as requiring multiple large atropine doses, respiratory depression/failure, fasciculations, seizures, dysrhythmias, hemodynamic instability.
| Parameter | Pediatric Dose |
|---|
| Loading dose | 25-50 mg/kg IV over 30 minutes (max 1-2 g) |
| Repeat | Can repeat as needed (up to hourly) based on response |
| Maintenance infusion | 10-20 mg/kg/h (adult equivalent: 500 mg/h or 8 mg/kg/h) up to 7 days |
| Endpoint | Improved mental status, respiratory rate/effort, heart rate, decreased secretions |
- Give as early as possible - before aging occurs
- If fat-soluble OPs are involved, patient may require prolonged infusion for weeks while awaiting new AChE synthesis
- Discontinue trial by withdrawing pralidoxime; if symptoms recur, continue therapy
-
- Rosen's Emergency Medicine, p. 1492-1493; Tintinalli's Emergency Medicine, p. 1344
Step 5: Benzodiazepines for Seizures
- Seizures are treated with benzodiazepines (diazepam, lorazepam, or midazolam)
- Phenytoin is NOT recommended for OP-induced seizures (no evidence of benefit)
- Standard pediatric weight-based dosing applies
Step 6: GI Decontamination
- Activated charcoal (1 g/kg, max 50 g) may be considered for recent oral ingestion (<1 hour) if airway is protected
- Gastric lavage rarely indicated and poses aspiration risk
- DO NOT induce vomiting
Cholinesterase Levels (Lab)
- Plasma butyrylcholinesterase - more available but less specific; easier to run
- RBC acetylcholinesterase - more accurate marker of synaptic inhibition
- Important: Do NOT wait for results before starting treatment. Treatment is clinical. Baseline variability and lack of standardized normal ranges limit these assays.
Disposition
| Severity | Disposition |
|---|
| Mild, asymptomatic | Observe in ED 4-6 hours minimum |
| Any symptoms | Admit for monitoring |
| Moderate-severe | Pediatric ICU |
| Respiratory failure, large atropine requirements | PICU with ventilator |
Most patients respond to pralidoxime with rising AChE levels within 48 hours. If no post-hypoxic brain damage and early treatment, symptomatic recovery occurs within approximately 10 days. Fat-soluble agents may require weeks of supportive care. - Tintinalli's Emergency Medicine, p. 1344
Special Pediatric Notes
- Carbamates (e.g., carbaryl) differ from OPs: they do NOT cause aging and spontaneously dissociate from AChE. Pralidoxime is generally not recommended for carbamate poisoning
- Diazinon and chlorpyrifos were removed from household use in the US in 2000 due to neurotoxicity on developing brains, but remain in use globally
- Consider child abuse or intentional poisoning if exposure history is inconsistent
- Always contact Poison Control (1-800-222-1222) early - they assist with specific product ingredient identification and management guidance
Quick Reference Summary Card
OP Poisoning in Peds:
1. Decontaminate (remove clothes, wash skin) + PPE for staff
2. Airway first - early intubation; avoid succinylcholine
3. ATROPINE: 0.05 mg/kg IV → double q5-10min → titrate to DRY secretions
4. PRALIDOXIME: 25-50 mg/kg IV over 30 min → infusion 10-20 mg/kg/h
5. BENZOS for seizures
6. PICU admission for moderate-severe cases
Sources: Tintinalli's Emergency Medicine, pp. 1342-1344; Rosen's Emergency Medicine, pp. 1492-1494